Davita - Harvey Dialysis is a medicare approved dialysis facility center in Harvey, Illinois and it has 18 dialysis stations. It is located in Cook county at 16641 S. Halsted St., Ste A, Harvey, IL, 60426. You can reach out to the office of Davita - Harvey Dialysis at (708) 210-9500. This dialysis clinic is managed and/or owned by Davita. Davita - Harvey Dialysis has the following ownership type - Profit. It was first certified by medicare in October, 2008. The medicare id for this facility is 142698 and it accepts patients under medicare ESRD program.
| Name | Davita - Harvey Dialysis |
|---|---|
| Location | 16641 S. Halsted St., Ste A, Harvey, Illinois |
| No. of Dialysis Stations | 18 |
| Medicare ID | 142698 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 16641 S. Halsted St., Ste A, Harvey, Illinois, 60426 | |
| (708) 210-9500 | |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
| NPI Number | 1144637224 |
| Organization Name | Harvey Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 16641 Halsted St Ste A Harvey, Illinois, 60426 |
| Phone Number | (708) 210-9500 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 38 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 32 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 79 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 681 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Harvey Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 85 |
| Hypercalcemia patient months | 753 |
| Patients with Serumphosphor | 85 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 14 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 60 |
| Patient months included in arterial venous fistula and catheter summaries | 444 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 42 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 18 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 68 |
| Hospitalization Rate in facility | 234.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 374.5 |
| Hospitalization Rate: Lower Confidence Limit | 151.3 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Harvey Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 33.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 44 |
| Readmission Rate: Lower Confidence Limit | 23.8 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Harvey Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .43 (As Expected) |
| SIR: Upper Confidence Limit | 1.43 |
| SIR: Lower Confidence Limit | .07 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Harvey Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 55 |
| Transfusion Rate in facility | 25.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 96 |
| Transfusion Rate: Lower Confidence Limit | 7.8 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Harvey Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 333 |
| Mortality Rate in facility | 14.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.1 |
| Mortality Rate: Lower Confidence Limit | 9.4 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago
Davita - Harvey Dialysis Location: 16641 S. Halsted St., Ste A, Harvey, Illinois, 60426 Phone: (708) 210-9500 |
News Archive
After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves - $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
Edward Maibach, Director, Center for Climate Change Communication; Faculty, Communication, received $250,000 from the Kresge Foundation for The Medical Society Consortium on Climate and Health.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
A new study from psychologists at the University of Bath highlights the true impact of heavy drinking on our ability to plan, set goals and make decisions the following day. Published in the Journal of Clinical Medicine, the study provides new evidence as to why hangovers cost the wider economy so much.
› Verified 6 days ago